These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14499692)

  • 1. T-cell prolymphocytic leukemia with der(11)t(1;11)(q21;q23) and ATM deficiency.
    Yamaguchi M; Yamamoto K; Miki T; Mizutani S; Miura O
    Cancer Genet Cytogenet; 2003 Oct; 146(1):22-6. PubMed ID: 14499692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell prolymphocytic leukemia with a novel translocation (6;11)(q21;q23).
    Wong KF; Chan JK; Sin VC
    Cancer Genet Cytogenet; 1999 Jun; 111(2):149-51. PubMed ID: 10347553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the ATM gene in T-cell prolymphocytic leukemias.
    Stoppa-Lyonnet D; Soulier J; Laugé A; Dastot H; Garand R; Sigaux F; Stern MH
    Blood; 1998 May; 91(10):3920-6. PubMed ID: 9573030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia.
    Stilgenbauer S; Schaffner C; Litterst A; Liebisch P; Gilad S; Bar-Shira A; James MR; Lichter P; Döhner H
    Nat Med; 1997 Oct; 3(10):1155-9. PubMed ID: 9334731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ataxia-telangiectasia and T-cell leukemias: no evidence for somatic ATM mutation in sporadic T-ALL or for hypermethylation of the ATM-NPAT/E14 bidirectional promoter in T-PLL.
    Luo L; Lu FM; Hart S; Foroni L; Rabbani H; Hammarström L; Yuille MR; Catovsky D; Webster AD; Vorechovský I
    Cancer Res; 1998 Jun; 58(11):2293-7. PubMed ID: 9622061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATM is usually rearranged in T-cell prolymphocytic leukaemia.
    Yuille MA; Coignet LJ; Abraham SM; Yaqub F; Luo L; Matutes E; Brito-Babapulle V; Vorechovský I; Dyer MJ; Catovsky D
    Oncogene; 1998 Feb; 16(6):789-96. PubMed ID: 9488043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM mutations in sporadic lymphoid tumours.
    Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
    Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.
    Vorechovský I; Luo L; Dyer MJ; Catovsky D; Amlot PL; Yaxley JC; Foroni L; Hammarström L; Webster AD; Yuille MA
    Nat Genet; 1997 Sep; 17(1):96-9. PubMed ID: 9288106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
    Boultwood J
    J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent ATM mutations in T-PLL on diverse haplotypes: no support for their germline origin.
    Stankovic T; Taylor AM; Yuille MR; Vorechovsky I
    Blood; 2001 Mar; 97(5):1517-8. PubMed ID: 11243240
    [No Abstract]   [Full Text] [Related]  

  • 11. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
    Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATM gene deletion in patients with adult acute lymphoblastic leukemia.
    Haidar MA; Kantarjian H; Manshouri T; Chang CY; O'Brien S; Freireich E; Keating M; Albitar M
    Cancer; 2000 Mar; 88(5):1057-62. PubMed ID: 10699895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.
    Starostik P; Manshouri T; O'Brien S; Freireich E; Kantarjian H; Haidar M; Lerner S; Keating M; Albitar M
    Cancer Res; 1998 Oct; 58(20):4552-7. PubMed ID: 9788599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations.
    Madani A; Choukroun V; Soulier J; Cacheux V; Claisse JF; Valensi F; Daliphard S; Cazin B; Levy V; Leblond V; Daniel MT; Sigaux F; Stern MH
    Blood; 1996 Mar; 87(5):1923-7. PubMed ID: 8634440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ataxia telangiectasia gene in familial and sporadic cancer.
    Yuille MA; Coignet LJ
    Recent Results Cancer Res; 1998; 154():156-73. PubMed ID: 10026998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of Novel
    Kanagal-Shamanna R; Bao H; Kearney H; Smoley S; Tang Z; Luthra R; Yang H; Zhang S; Lin P; Wu D; Medeiros LJ; Lu X
    Leuk Lymphoma; 2022 Apr; 63(4):865-875. PubMed ID: 34898335
    [No Abstract]   [Full Text] [Related]  

  • 18. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
    Drexler HG; Quentmeier H; MacLeod RA
    Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mantle cell lymphoma is characterized by inactivation of the ATM gene.
    Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2773-8. PubMed ID: 10706620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No germline ATM mutation in a series of 16T-cell prolymphocytic leukemias.
    Stoppa-Lyonnet D; Laugé A; Sigaux F; Stern MH
    Blood; 2000 Jul; 96(1):374-6. PubMed ID: 10939806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.